Astrazeneca (AZN) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Astrazeneca (AZN) over the last 14 years, with Q4 2025 value amounting to -$1.7 billion.
- Astrazeneca's Other Gross PP&E Adjustments fell 2480.29% to -$1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.7 billion, marking a year-over-year decrease of 2480.29%. This contributed to the annual value of -$1.7 billion for FY2025, which is 2480.29% down from last year.
- According to the latest figures from Q4 2025, Astrazeneca's Other Gross PP&E Adjustments is -$1.7 billion, which was down 2480.29% from -$1.7 billion recorded in Q3 2025.
- Astrazeneca's 5-year Other Gross PP&E Adjustments high stood at -$660.0 million for Q1 2021, and its period low was -$1.7 billion during Q4 2025.
- Its 5-year average for Other Gross PP&E Adjustments is -$1.1 billion, with a median of -$982.5 million in 2021.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 9340.0% in 2021, then skyrocketed by 770.04% in 2022.
- Quarter analysis of 5 years shows Astrazeneca's Other Gross PP&E Adjustments stood at -$988.0 million in 2021, then grew by 4.66% to -$942.0 million in 2022, then dropped by 16.77% to -$1.1 billion in 2023, then decreased by 26.82% to -$1.4 billion in 2024, then decreased by 24.8% to -$1.7 billion in 2025.
- Its Other Gross PP&E Adjustments was -$1.7 billion in Q4 2025, compared to -$1.7 billion in Q3 2025 and -$1.6 billion in Q2 2025.